Brief: Janone Readies Clinical Supply Of Lead Product Candidate Jan101 For Distribution To Phase 2B Trial Sites
June 23 (Reuters) - Janone Inc JAN.O :
* JANONE READIES CLINICAL SUPPLY OF LEAD PRODUCT CANDIDATE
JAN101
FOR DISTRIBUTION TO PHASE 2B TRIAL SITES
* JANONE INC - FULLY PREPARED TO COMMENCE PHASE 2B TRIALS OF
JAN101 FOR PERIPHERAL ARTERY DISEASE (PAD) AS SOON AS NEW
PROTOCOL IS APPROVED BY FDA
Source text for Eikon: ID:nPncch431a
Further company coverage: JAN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AI Financial
See all newsBrief: ALT5 Sigma Corporation Restores Compliance With Nasdaq Periodic Filing Requirements
Brief: Alt5 Sigma Expects To File Its Quarterly Report On Form 10-Q
Media: Trump-linked crypto venture Alt5 Sigma retains auditor - FT
Brief: ALT5 Sigma Corporation Provides Corporate Update
American Bitcoin steadies after share lock-up expiry sparks near 40% plunge (updated)